Invasive fungal disease after remote inoculation in transplant recipients.
نویسندگان
چکیده
We describe 3 cases of invasive fungal disease in the setting of transplantation-associated immunosuppression, developing months to years after clinically resolved penetrating soft-tissue injuries with wood fragments. Invasive fungal disease resulting from remote inoculation is a distinct syndrome in immunocompromised patients presenting with soft-tissue abnormalities in areas of prior trauma.
منابع مشابه
Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients?
Fungal infections have historically been, and remain important causes of transplant-related morbidity in recipients of hematopoietic stem cell transplant (HSCT). However, there have been notable changes in the epidemiology and outcomes of invasive fungal infections, induced by changes in the transplant procedures as well as supportive care. This review discusses invasive fungal infections in he...
متن کاملFungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
OBJECTIVES Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. MATERIALS AND METHODS An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant reci...
متن کاملMucormycosis in organ and stem cell transplant recipients.
Mucormycosis is a devastating invasive fungal disease whose incidence has increased during the past decade. Mucormycosis now represents a major threat in transplant recipients, accounting for 2% and 8% of invasive fungal infections in recent cohorts of solid-organ and allogeneic stem-cell transplant recipients, respectively. Mucormycosis most often occurs late, >3 months after transplantation, ...
متن کاملVoriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
BACKGROUND Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the success of stem cell transplantation. Secondary prophylaxis could reduce disease burden and improve survival. DESIGN AND METHODS A prospective, open-label, multicenter trial was conducted evaluating voriconazole (4 mg/kg/12 h intravenously or 200 mg/12 h orally) as secondary antifungal prophylaxis in ...
متن کاملImmunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients suffer from a long lasting defect of different arms of the immune system, which increases the risk for and deteriorates the prognosis of invas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
دوره 52 1 شماره
صفحات -
تاریخ انتشار 2011